TRANSWELL BIOTECH CO., LTD.

Area: Cell Therapy and Regenerative Medicine

Booth No: M626

Exhibitor Profile

Transwell Biotech Co., Ltd. focuses on the development and clinical application of advanced biological wound dressing, TWB-103, which combines allogeneic skin fibroblasts with a hydrogel carrier and is applied to acute, chronic and surgical wounds. Two human clinical trials have been completed and approved by the Ministry of Health and Welfare, including a "Phase I/II trial for the Treatment of Surgical Donor Site Wounds" and a "Phase I trial for the Treatment of Diabetic Lower Limb Ulcers."

Brands

TWB-103 Dermal Fibroblast Cell Therapy Product, EpiV Serum-free Epithelial Cell Culture Medium, Hydrogel Wound Products, Exosome, Keratinocyte、UCMSC.

Video

Menu

TRANSWELL BIOTECH CO., LTD.

Exhibitor Profile

Brands

Video

Introduction to TRANSWELL BIOTECH CO., LTD.

Exhibit Products

Exhibitors you may be interested in

Highest Rated